Spectroscopy specialist Starna Scientific has appointed Nathan Hulme as a director to help guide the company’s expansion plans.
Hulme’s main responsibilities will include assisting in setting out a business strategy for the company that will address communications with customers and dealers as well as involving leadership of the sales team.
A graduate from Merton College, Oxford University, Hulme has a degree in Philosophy, Politics & Economics (PPE), specialising in Finance and International Economics.
He has also completed a mini-MBA at Tanaka Business School, Imperial College that featured finance, strategy and marketing components.
Starna Scientific appoints Nathan Hulme as a director
To help guide expansion plans at the spectroscopy specialist
You may also like
Analysis
Compact, cost-effective flow sensor with differential pressure technology developed for demanding laboratory systems
Bürkert, a pioneer in flow control, has announced the release of a new flow sensor using differential pressure technology that offers enhanced performance from continuous measurement alongside increased process safety in a space-saving, cost-effective design
Analysis
Inspection readiness should be part of normal operations
For routine surveillance inspections, readiness cannot depend on receiving advance notice. Inspection readiness should be embedded in everyday operations, while recognising that preparation may need to become more intensive ahead of a known regulatory milestone
Research & Development
Bio-Rad expands precision oncology research portfolio for advanced molecular analysis workflows
Expanded portfolio Includes new droplet digital PCR assays, Reagents and technologies to support oncology research applications and extend the capabilities of the QX700 ddPCR systems
Analysis
Quality culture becomes visible during an inspection
Quality culture can sound intangible, but investigators encounter evidence of it throughout an inspection. Is your quality system ready for regulatory scrutiny? Former FDA investigator Dr. Julia Marré shares practical guidance on quality culture, site preparation and effective Form FDA 483 responses
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.